Investors Connect Biopharma is clinical-stage biopharmaceutical company focused on transforming acute and chronic care in Asthma and Chronic Obstructive Pulmonary Disease (COPD) Press Releases September 3, 2026 Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference August 12, 2026 Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update June 17, 2026 Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma FRONT >> News > View All View all press releases Upcoming Events H.C. Wainwright 28th Annual Global Investment Conference September 15, 2026 at 11:30 AM EDT Register Here Link to H.C. Wainwright 28th Annual Global Investment Conference webcast FRONT > Events - View All View all events Stock Quote Change Volume Today's Open Previous Close Minimum 15 minutes delayed. Source: LSEG FRONT >> Stock > View All View detailed stock information
September 3, 2026 Connect Biopharma to Present at the H.C. Wainwright 28th Annual Global Investment Conference
August 12, 2026 Connect Biopharma Reports Second Quarter 2026 Financial Results and Provides Business Update
June 17, 2026 Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma
